On the public citation graph

Design and Development of Efficient Synthetic Strategies for Novel B-Lactam Enhancer Wck 5153 Effective Against Gram-Negative Pathogens

0 signed · 12 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s40265-017-0851-9openalex-extracted

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

inferredcites →https://doi.org/10.1016/j.biotechadv.2018.11.013openalex-extracted

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

inferredcites →https://doi.org/10.1016/j.coph.2019.03.004openalex-extracted

Recently developed synthetic compounds with anti-infective activity

inferredcites →https://doi.org/10.1016/j.jmb.2019.04.002openalex-extracted

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

inferredcites →https://doi.org/10.1016/j.tetlet.2007.06.106openalex-extracted

A rapid and convenient synthesis of β-proline

inferredcites →https://doi.org/10.1021/acs.jmedchem.8b00091openalex-extracted

Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234

inferredcites →https://doi.org/10.1021/jo400236fopenalex-extracted

Overcoming Resistance to β-Lactam Antibiotics

inferredcites →https://doi.org/10.1021/op034103oopenalex-extracted

A Practical Synthesis of the Platelet Fibrinogen Antagonist, Elarofiban

inferredcites →https://doi.org/10.1038/s41392-022-01056-1openalex-extracted

Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics

inferredcites →https://doi.org/10.1039/c9ob02605copenalex-extracted

Synthetic approaches towards avibactam and other diazabicyclooctane β-lactamase inhibitors

inferredcites →https://doi.org/10.1080/14787210.2020.1756775openalex-extracted

Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination

inferredcites →https://doi.org/10.1093/jac/dkh358openalex-extracted

In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.